Both HIF-1 and HIF-2 play major roles in retinal neovascularization, and, in mouse models, a small-molecule dual HIF-1/HIF-2 inhibitor safely and effectively blocks the development of macular edema and ischemic retinal neovascularization, which are the causes of vision loss associated with diabetes (15). Here, HIF1A is linked to diabetes mellitus.